EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Shikimic acid (SA) inhibits neuro-inflammation and exerts neuroprotective effects in an LPS-induced in vitro and in vivo model

Xueying Bao, Zhuangzhuang Zheng, Jincai Lv, Jindian Bao, Sitong Chang, Xin Jiang, Ying Xin

Frontiers in Pharmacology · 02.11.2023 · 14

DOI: 10.3389/fphar.2023.1265571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 02.11.2023. Verfasst von Xueying Bao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The First Hospital of Jilin University, Changchun, China. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Numerous studies have shown that neuroinflammation is involved in the process of neuronal damage in neurodegenerative diseases such as Parkinson’s disease (PD), for example, and that inhibiting neuroinflammation help improve PD. Shikimic acid (SA) has anti-inflammatory, analgesic and antioxidant activities in numerous diseases. However, its effect and mechanism in PD remain unclear. In this experiment, we found that SA inhibits production of pro-inflammatory mediators and ROS in LPS-induced BV2 cells. Mechanistic studies demonstrated that SA suppresses neuro-inflammation by activating the AKT/Nrf2 pathway and inhibiting the NF-κB pathway. Further in vivo study, we confirmed that SA ameliorated the neurological damage and behavioral deficits caused by LPS injection in mice. In summary, these study highlighted the beneficial role of SA as a novel therapy with potential PD drug by targeting neuro-inflammation.

Schlagwörter

Stichwörter der Autor:innen

microglianeuro-inflammationneuroprotectionparkinson’s diseaseshikimic acid

Autor:innen und Institutionen

  • Department of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.
  • Jilin Provincial Key Laboratory of Radiation Oncology and Therapy, The First Hospital of Jilin University, Changchun, China.
  • NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, China.
  • Key Laboratory of Pathobiology, Ministry of Education, and College of Basic Medical Science, Jilin University, Changchun, China.

Zitieren

APA

Bao, X., Zheng, Z., Lv, J., Bao, J., Chang, S., Jiang, X., & Xin, Y. (2023). Shikimic acid (SA) inhibits neuro-inflammation and exerts neuroprotective effects in an LPS-induced in vitro and in vivo model. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1265571

Vancouver

Bao X, Zheng Z, Lv J, Bao J, Chang S, Jiang X, et al. Shikimic acid (SA) inhibits neuro-inflammation and exerts neuroprotective effects in an LPS-induced in vitro and in vivo model. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1265571

BibTeX
@article{Bao2023,
  author = {Bao, Xueying and Zheng, Zhuangzhuang and Lv, Jincai and Bao, Jindian and Chang, Sitong and Jiang, Xin and Xin, Ying},
  title = {Shikimic acid (SA) inhibits neuro-inflammation and exerts neuroprotective effects in an LPS-induced in vitro and in vivo model},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1265571}
}
Kostenlos starten →